APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | +24.1% | +33.3% | – | – | +93.2% | +0.0% | -200.0% | – | – | – | |
| – | – | – | – | – | – | -418.5% | – | – | – | -202.0% | – | – | |
| – | +69.6% | -0.8% | +15.6% | +37.7% | +31.8% | -23.0% | +20.1% | -2.7% | +7.9% | +4.1% | +10.7% | – | |
| – | +13.3% | +15.4% | +15.3% | +18.8% | +20.7% | +5.8% | +3.4% | -0.2% | +17.4% | +9.3% | +10.9% | – | |
| – | +52.9% | +2.8% | +15.6% | +33.0% | +29.3% | -16.8% | +16.0% | -3.1% | +10.7% | +5.0% | +16.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -101.1% | – | – | – | – | +361.1% | -13.3% | -15.3% | +1.6% | +27.4% | -1.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.